Fitch TR - Search Results

1

Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity.

Kanard A, Jatoi A, Castillo R, Geyer S, Schulz TK, Fitch TR, Rowland KM, Nair S, Krook JE, Kugler JW. Kanard A, et al. Among authors: fitch tr. Lung Cancer. 2004 Mar;43(3):345-53. doi: 10.1016/j.lungcan.2003.09.012. Lung Cancer. 2004. PMID: 15165094 Clinical Trial.

2

A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer.

Molina JR, Nikcevich D, Hillman S, Geyer S, Drevyanko T, Jett J, Verdirame J, Tazelaar H, Rowland K, Wos E, Kutteh L, Nair S, Fitch T, Flynn P, Stella P, Adjei AA. Molina JR, et al. Cancer Invest. 2006 Jun-Jul;24(4):382-9. doi: 10.1080/07357900600705318. Cancer Invest. 2006. PMID: 16777690 Clinical Trial.

3

Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinoma.

Hobday TJ, Kugler JW, Mahoney MR, Sargent DJ, Sloan JA, Fitch TR, Krook JE, O'Connell MJ, Mailliard JA, Tirona MT, Tschetter LK, Cobau CD, Goldberg RM. Hobday TJ, et al. Among authors: fitch tr. J Clin Oncol. 2002 Dec 1;20(23):4574-80. doi: 10.1200/JCO.2002.08.535. J Clin Oncol. 2002. PMID: 12454115 Clinical Trial.

4

A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma.

Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CY, Flynn PJ. Jatoi A, et al. Among authors: fitch tr. Cancer. 2003 Mar 15;97(6):1442-6. doi: 10.1002/cncr.11200. Cancer. 2003. PMID: 12627508 Free article. Clinical Trial.

5

A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer.

Marks RS, Graham DL, Sloan JA, Hillman S, Fishkoff S, Krook JE, Okuno SH, Mailliard JA, Fitch TR, Addo F. Marks RS, et al. Among authors: fitch tr. Am J Clin Oncol. 2003 Aug;26(4):336-7. doi: 10.1097/01.COC.0000020962.25210.6F. Am J Clin Oncol. 2003. PMID: 12902880 Clinical Trial.

6

Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both.

Perez EA, Hillman DW, Mailliard JA, Ingle JN, Ryan JM, Fitch TR, Rowland KM, Kardinal CG, Krook JE, Kugler JW, Dakhil SR. Perez EA, et al. Among authors: fitch tr. J Clin Oncol. 2004 Jul 15;22(14):2849-55. doi: 10.1200/JCO.2004.10.047. J Clin Oncol. 2004. PMID: 15254052 Clinical Trial.

7

Gemcitabine and ISIS-2503 for patients with locally advanced or metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II trial.

Alberts SR, Schroeder M, Erlichman C, Steen PD, Foster NR, Moore DF Jr, Rowland KM Jr, Nair S, Tschetter LK, Fitch TR. Alberts SR, et al. Among authors: fitch tr. J Clin Oncol. 2004 Dec 15;22(24):4944-50. doi: 10.1200/JCO.2004.05.034. J Clin Oncol. 2004. PMID: 15611509 Clinical Trial.

8

Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer.

Ma CX, Nair S, Thomas S, Mandrekar SJ, Nikcevich DA, Rowland KM, Fitch TR, Windschitl HE, Hillman SL, Schild SE, Jett JR, Obasaju C, Adjei AA; North Central Cancer Treatment Group; Mayo Clinic; Eli Lilly & Company. Ma CX, et al. Among authors: fitch tr. J Clin Oncol. 2005 Sep 1;23(25):5929-37. doi: 10.1200/JCO.2005.13.953. J Clin Oncol. 2005. PMID: 16135464 Clinical Trial.

9

A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.

Jatoi A, Dakhil SR, Nguyen PL, Sloan JA, Kugler JW, Rowland KM Jr, Soori GS, Wender DB, Fitch TR, Novotny PJ, Loprinzi CL. Jatoi A, et al. Among authors: fitch tr. Cancer. 2007 Sep 15;110(6):1396-403. doi: 10.1002/cncr.22944. Cancer. 2007. PMID: 17674351 Free article. Clinical Trial.

10

Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).

Johnson EA, Marks RS, Mandrekar SJ, Hillman SL, Hauge MD, Bauman MD, Wos EJ, Moore DF, Kugler JW, Windschitl HE, Graham DL, Bernath AM Jr, Fitch TR, Soori GS, Jett JR, Adjei AA, Perez EA. Johnson EA, et al. Among authors: fitch tr. Lung Cancer. 2008 May;60(2):200-7. doi: 10.1016/j.lungcan.2007.10.003. Epub 2007 Nov 28. Lung Cancer. 2008. PMID: 18045731 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters